Lynch
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If Lynch is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- Urinary and Faecal Amino-Acids as Biomarkers for Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Study. · Int J Cancer · 2026-08-22
- GALT/Dome Adenocarcinoma in a Patient With MLH1-Deficient Lynch Syndrome: Navigating a Clinical and Management Dilemma. · ACG Case Rep J · 2026-08-14
- Structured surveillance in Lynch syndrome: effectiveness, limitations, and unmet needs. · ESMO Gastrointest Oncol · 2026-08-10
- Universal Tumor Screening in Colorectal Cancer: Role of MMR Immunohistochemistry for Lynch Syndrome and Early-Onset CRC. · Cancers (Basel) · 2026-08-08
- Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome: a national observational cohort study of patients in the English NHS 2010-2022. · Gut · 2026-08-06
- Clinical utility and cost-effectiveness of universal tumor screening to identify Lynch syndrome in patients with stage II/III colorectal cancer: a prospective observational study in Japan. · Int J Clin Oncol · 2026-08-04
What the reporting says
It shows up alongside Colorectal Cancer (19).
Two steps out: Braf (through Colorectal Cancer, 19 shared stories on the weaker link); Chen (through Colorectal Cancer, 19 shared stories on the weaker link); ctDNA (through Colorectal Cancer, 19 shared stories on the weaker link); Egfr (through Colorectal Cancer, 19 shared stories on the weaker link).
Tracked since Dec 31, with coverage on 31 separate days — concentrated in Pubmed Targeted and Oncology.